Postnatal development of the dopaminergic signaling involved in the modulation of intestinal motility in mice

Pediatr Res. 2016 Sep;80(3):440-7. doi: 10.1038/pr.2016.91. Epub 2016 Apr 18.

Abstract

Background: Since antidopaminergic drugs are pharmacological agents employed in the management of gastrointestinal motor disorders at all ages, we investigated whether the enteric dopaminergic system may undergo developmental changes after birth.

Methods: Intestinal mechanical activity was examined in vitro as changes in isometric tension.

Results: In 2-d-old (P2) mice, dopamine induced a contractile effect, decreasing in intensity with age, replaced, at the weaning (day 20), by a relaxant response. Both responses were tetrodotoxin (TTX)-insensitive. In P2, dopaminergic contraction was inhibited by D1-like receptor antagonist and mimicked by D1-like receptor agonist. In 90-d-old (P90) mice, the relaxation was reduced by both D1- and D2-like receptor antagonists, and mimicked by D1- and D2-like receptor agonists. In P2, contraction was antagonized by phospholipase C inhibitor, while in P90 relaxation was antagonized by adenylyl cyclase inhibitor and potentiated by phospholipase C inhibitor. The presence of dopamine receptors was assessed by immunofluorescence. Quantitative real-time polymerase chain reaction (qRT-PCR) revealed a significant increase in D1, D2, and D3 receptor expression in proximal intestine with the age.

Conclusion: In mouse small intestine, the response to dopamine undergoes developmental changes shifting from contraction to relaxation at weaning, as the consequence of D2-like receptor recruitment and increased expression of D1 receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Animals
  • Animals, Newborn
  • Cyclic AMP / metabolism
  • Dideoxyadenosine / pharmacology
  • Dopamine / physiology*
  • Enteric Nervous System / physiology
  • Estrenes / pharmacology
  • Gastrointestinal Diseases / pathology
  • Gastrointestinal Motility / physiology*
  • Intestine, Small / growth & development*
  • Intestine, Small / physiology
  • Mice
  • Mice, Inbred C57BL
  • Pyrrolidinones / pharmacology
  • Signal Transduction / drug effects
  • Tetrodotoxin / chemistry
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / metabolism

Substances

  • Estrenes
  • Pyrrolidinones
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Tetrodotoxin
  • Dideoxyadenosine
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Cyclic AMP
  • Type C Phospholipases
  • Dopamine